Archive
Brokers: Sirius Minerals, Rolls-Royce, Glencore, Allergy..
WH Ireland suggests the recent weakness in fertiliser group Sirius Minerals is an opportunity.
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 14 of 15
Archive
Proactive news highlights - Allergy Therapeutics, Mosman Oil & Gas, PureCircle and Stratex
Looking outside it might seem too early, but hay fever vaccine specialist Allergy Therapeutics is preparing for summer. .
Allergy Therapeutics enrols 250 for grass pollen allergy trial
The dose-setting trial for the vaccine, GrassMATAMPL, will involve 250 patients.
Archive
Proactive news summary: Ariana, Allergy Therapeutics, Epistem, Instem, IOG, Kibo, Metal Tiger ...
A round-up of the day's news from the small cap universe
Allergy Therapeutics posts double digit revenue growth
The company expects revenues to be in the order of £31.5mln in the first half of its financial year, which equates to a 12% rise at constant currencies.
e-Therapeutics hires life sciences veteran as chairman
Professor Malcolm Young is stepping down as chairman but will remain in his role as chief executive.
Archive
Brokers: ASOS to top the retail tree over Christmas
ASOS, Boo and SuperGroup to have full stockings, while M&S, Halfords and SPorts Direct may be disappointed says Peel Hunt
Allergy Therapeutics could gain from rival's problems, says Panmure
French group Stallergenes had to temporarily close its Antony manufacturing plant
Investments and investor services
Markets: Oil stocks push FTSE100 lower
The FTSE100 ended the day almost 15 points lower to 6,223.
Investments and investor services
Proactive news highlights: IOG, Motif Bio, allergy Therapeutics, ReNeuron, Immupharma and more
Sunrise Resources, Optibiotix Health and ITM Power also had news out
Markets: InternetQ hits back at online blog post
The FTSE100 was around 30 points higher at 6,267 with aerospace engine maker Rolls Royce leading the way.
Investments and investor services
Markets rise despite downbeat UK manufacturing news
The Footsie rose 30.9 points to 6269.19 while mainland European markets also gained
Allergy Therapeutics starts enrolment for US grass allergy trial
Up to half of the US suffers from inflammation and sneezing associated with seasonal allergic rhinitis/conjunctivitis
Investments and investor services
Proactive news highlights: Berkeley Energia, Acal, Clinigen, ZincOx, Sula Iron & Gold and more
Ferrex, Oilex and Allergy Therapeutics also had news out on Monday
Allergy Therapeutics ready to begin phase II trials on birch pollen innoculation
The point of the investigation is to find the optimal dose as well as assessing efficacy.
Investments and investor services
Proactive highlights - Allergy Therapeutics, Angle, Summit, VolitionRx, Faron Pharma, Camco Clean Energy, Mobile Streams & more
Here we take our daily look at the small cap news highlights of the trading day
Investments and investor services
Risers & Fallers: React Group, WS Atkins, Oilex, Carclo, Ferrex and Anglo American
Below are the main news-driven share price movements at 4pm.
Allergy Therapeutics raising £12mln for market step change
It said it will issue stock at 28p, using the proceeds to invest for new product development.
Archive
Proactive news summary: Allergy Therapeutics, Berkeley Energy, Forbidden Technologies, Gemfields ...
Pride of place goes to Plethora Solutions, after Jim Mellon's Regent Pacific offered to take it over.
Allergy Therapeutics to present data at World Vaccine Congress
It is an excellent opportunity to present this exciting data, says CSO Dr Murray Skinner